VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boynton Beach private club has ...

At the same time, VIS-101 is also an important driver, and I apologise for now focusing on it too much. It provides a second leg to the story here, with a Phase 2b initiation expected sometime in 2H26 ...

Secure Ad Serving (HTTPS): All third-party served creatives and their components (images, stylesheets, JavaScript, tracking pixels, etc.) must be secure (HTTPS) to ensure compliance and correct ...

An AI-Powered Job Discovery and Recruitment Platform with privacy-first local LLMs, intelligent candidate-to-job matching, skill graph mapping, and delta resume storage. FINDING_AI is a ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...